136 related articles for article (PubMed ID: 7965393)
21. Prognostic role of the tumor-associated tissue inflammatory reaction in transitional bladder cell carcinoma.
Cai T; Nesi G; Boddi V; Mazzoli S; Dal Canto M; Bartoletti R
Oncol Rep; 2006 Aug; 16(2):329-34. PubMed ID: 16820911
[TBL] [Abstract][Full Text] [Related]
22. Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade.
Nocito A; Bubendorf L; Tinner EM; Süess K; Wagner U; Forster T; Kononen J; Fijan A; Bruderer J; Schmid U; Ackermann D; Maurer R; Alund G; Knönagel H; Rist M; Anabitarte M; Hering F; Hardmeier T; Schoenenberger AJ; Flury R; Jäger P; Fehr JL; Schraml P; Moch H; Mihatsch MJ; Gasser T; Sauter G
J Pathol; 2001 Jul; 194(3):349-57. PubMed ID: 11439368
[TBL] [Abstract][Full Text] [Related]
23. Pretreatment p53 nuclear overexpression as a prognostic marker in superficial bladder cancer treated with Bacillus Calmette-Guérin (BCG).
Saint F; Le Frere Belda MA; Quintela R; Hoznek A; Patard JJ; Bellot J; Popov Z; Zafrani ES; Abbou CC; Chopin DK; de Medina SG
Eur Urol; 2004 Apr; 45(4):475-82. PubMed ID: 15041112
[TBL] [Abstract][Full Text] [Related]
24. [Multivariable analysis of survival in patients with transitional cell bladder carcinoma].
Li J; Xu X; Ding J
Zhonghua Wai Ke Za Zhi; 1995 Jun; 33(6):353-4. PubMed ID: 8582219
[TBL] [Abstract][Full Text] [Related]
25. The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour.
Solsona E; Iborra I; Rubio J; Casanova J; Almenar S
BJU Int; 2004 Dec; 94(9):1258-62. PubMed ID: 15610101
[TBL] [Abstract][Full Text] [Related]
26. Expression of p53 protein has no independent prognostic value in breast cancer.
Pietiläinen T; Lipponen P; Aaltomaa S; Eskelinen M; Kosma VM; Syrjänen K
J Pathol; 1995 Nov; 177(3):225-32. PubMed ID: 8551383
[TBL] [Abstract][Full Text] [Related]
27. Prognosis of transitional cell bladder cancer: a multivariate prognostic score for improved prediction.
Lipponen PK; Eskelinen MJ; Kiviranta J; Pesonen E
J Urol; 1991 Dec; 146(6):1535-40. PubMed ID: 1942335
[TBL] [Abstract][Full Text] [Related]
28. Nm23-H1 protein, DNA-ploidy and S-phase fraction in relation to overall survival and disease free survival in transitional cell carcinoma of the bladder.
Alderisio M; Cenci M; Valli C; Russo A; Bazan V; Dardanoni G; Cucciarre S; Carreca I; Macaluso MP; Tomasino RM; Vecchione A
Anticancer Res; 1998; 18(6A):4225-30. PubMed ID: 9891471
[TBL] [Abstract][Full Text] [Related]
29. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
Słojewski M
Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
[TBL] [Abstract][Full Text] [Related]
30. [Clinical course of superficial transitional carcinoma of the bladder without poor prognostic factors].
Arrizabalaga Moreno M; Castro Pita M; Díez Rodríguez JM; García González JI; Navarro Sebastián J; Extramiana Cameno J; Esteban Artiaga R; Paniagaa Andrés P
Actas Urol Esp; 1997 Mar; 21(3):187-94. PubMed ID: 9324883
[TBL] [Abstract][Full Text] [Related]
31. Reproducibility and prognostic variability of grade and lamina propria invasion in stages Ta, T1 urothelial carcinoma of the bladder.
Bol MG; Baak JP; Buhr-Wildhagen S; Kruse AJ; Kjellevold KH; Janssen EA; Mestad O; Øgreid P
J Urol; 2003 Apr; 169(4):1291-4. PubMed ID: 12629345
[TBL] [Abstract][Full Text] [Related]
32. Association of positive serum anti-p53 antibodies with poor prognosis in bladder cancer patients.
Gumus E; Erdamar S; Demirel G; Horasanli K; Kendirci M; Miroglu C
Int J Urol; 2004 Dec; 11(12):1070-7. PubMed ID: 15663677
[TBL] [Abstract][Full Text] [Related]
33. [Evaluations of protein p53 overexpression in cancer of the bladder: prognostic value].
Popov Z; Hoznek A; Colombel M; Bastuji S; Abbou CC; Chopin DK
Chirurgie; 1996; 121(6):461-9. PubMed ID: 8978142
[TBL] [Abstract][Full Text] [Related]
34. Independent clinical, histological and quantitative prognostic factors in transitional-cell bladder tumours, with special reference to mitotic frequency.
Lipponen PK; Eskelinen MJ; Jauhiainen K; Harju E; Terho R; Haapasalo H
Int J Cancer; 1992 May; 51(3):396-403. PubMed ID: 1592531
[TBL] [Abstract][Full Text] [Related]
35. How to count mitoses in bladder cancer grading?
Lipponen PK; Eskelinen MJ
Anticancer Res; 1991; 11(2):825-9. PubMed ID: 2064337
[TBL] [Abstract][Full Text] [Related]
36. [Nucleolar organizers in superficial bladder tumors. Prognostic analysis of 37 observations].
Clement T; Visseaux-Coletto B; Adnet JJ; Ploton D; Lardennois B
Prog Urol; 1991 Apr; 1(2):216-29. PubMed ID: 1844824
[TBL] [Abstract][Full Text] [Related]
37. Proliferation indices as independent prognostic factors in papillary Ta-T1 transitional cell bladder tumours.
Lipponen PK; Eskelinen MJ; Jauhiainen K; Terho R; Nordling S
Br J Urol; 1993 Oct; 72(4):451-7. PubMed ID: 8261303
[TBL] [Abstract][Full Text] [Related]
38. Grading of superficial bladder cancer by quantitative mitotic frequency analysis.
Lipponen PK; Eskelinen MJ; Jauhiainen K; Harju E; Terho R; Haapasalo H
J Urol; 1993 Jan; 149(1):36-41. PubMed ID: 8417213
[TBL] [Abstract][Full Text] [Related]
39. Flow cytometry in comparison with mitotic index in predicting disease outcome in transitional-cell bladder cancer.
Lipponen PK; Nordling S; Eskelinen MJ; Jauhiainen K; Terho R; Harju E
Int J Cancer; 1993 Jan; 53(1):42-7. PubMed ID: 8416203
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of MIB-1 score, p53, EGFr, mitotic index and papillary status in primary superficial (Stage pTa/T1) bladder cancer: a prospective comparative study. The Finnbladder Group.
Liukkonen T; Rajala P; Raitanen M; Rintala E; Kaasinen E; Lipponen P
Eur Urol; 1999 Nov; 36(5):393-400. PubMed ID: 10516448
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
